In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA's Overreach on Compounded Peptides FDA mulls compounding for peptides previously flagged over safety risks BioSpace Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida